EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bile Acids in Autoimmune Liver Disease: Unveiling the Nexus of Inflammation, Inflammatory Cells, and Treatment Strategies

Tianhao Zhou iD, AbdiGhani Ismail, Heather Francis

Cells · 2023

DOI: 10.3390/cells12232725 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Tianhao Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Hauptthemen laut MEDLINE: Liver Diseases, Hepatitis, Autoimmune. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Strategic Research Initiative funds, Indiana University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As bile acids not solely play an essential role in nutrition absorption, but also in regulating metabolic functions as well as immune response, bile acids and their signaling pathways are increasingly acknowledged as potential therapeutic targets in the context of chronic liver diseases. Bile acid receptors such as G protein bile acid-activated receptor 1 and farnesoid X receptor are expressed in different immune cells engaged in innate immunity. Recently, a series of studies have revealed distinct functions of bile acids and bile acid receptors within the adaptive immune system. In addition, a variety of molecules targeting bile acid receptors and transporters are currently in advanced stages of clinical development. Autoimmune liver diseases including conditions like primary biliary cholangitis, primary sclerosing cholangitis, and autoimmune hepatitis can lead to chronic inflammation, fibrosis, and even cirrhosis and liver failure. In this review, we focus on the role of bile acids in the inflammatory aspects of autoimmune liver diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver DiseasesHepatitis, AutoimmuneHumansBile Acids and SaltsInflammationSignal Transduction

Stichwörter der Autor:innen

ASBTFXRGPBAR1bile acidsliver diseases

Substanzen

Bile Acids and Salts

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Department of Research, Richard L. Roudebush VA Medical Center, Indianapolis, IN 46202, USA.

ORCID-Profile: Tianhao Zhou

Förderung

  • Strategic Research Initiative funds, Indiana University

Zitieren

APA

Zhou, T., Ismail, A., & Francis, H. (2023). Bile Acids in Autoimmune Liver Disease: Unveiling the Nexus of Inflammation, Inflammatory Cells, and Treatment Strategies. Cells. https://doi.org/10.3390/cells12232725

Vancouver

Zhou T, Ismail A, Francis H. Bile Acids in Autoimmune Liver Disease: Unveiling the Nexus of Inflammation, Inflammatory Cells, and Treatment Strategies. Cells. 2023. doi:10.3390/cells12232725

BibTeX
@article{Zhou2023,
  author = {Zhou, Tianhao and Ismail, AbdiGhani and Francis, Heather},
  title = {Bile Acids in Autoimmune Liver Disease: Unveiling the Nexus of Inflammation, Inflammatory Cells, and Treatment Strategies},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12232725}
}
Kostenlos starten →